Novel Biologics for the Treatment of Pediatric Severe Asthma

被引：1

作者：

Licari, Amelia ^{[1
,2
]}

Castagnoli, Riccardo ^{[2
]}

Tondina, Enrico ^{[2
]}

Testa, Giorgia ^{[1
]}

Parisi, Giuseppe Fabio ^{[3
]}

Marseglia, Alessia ^{[2
]}

Brambilla, Ilaria ^{[1
,2
]}

Marseglia, Gian Luigi ^{[1
,2
]}

机构：

[1] Fdn IRCCS Policlin San Matteo, SC Pediat, Pavia, Italy

[2] Univ Pavia, Dept Pediat, Pavia, Italy

[3] Univ Catania, Dept Clin & Expt Med, Catania, Italy

来源：

CURRENT RESPIRATORY MEDICINE REVIEWS | 2019年 / 15卷 / 03期

关键词：

Benralizumab; children; dupilumab; mepolizumab; omalizumab; reslizumab; severe asthma; SEVERE EOSINOPHILIC ASTHMA; SEVERE ALLERGIC-ASTHMA; ANTI-IGE; IMMUNOGLOBULIN-E; DOUBLE-BLIND; AIRWAY INFLAMMATION; MONOCLONAL-ANTIBODY; QGE031; LIGELIZUMAB; RANDOMIZED-TRIAL; SERUM IGE;

D O I：

10.2174/1573398X15666190521111816

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

Estimated to represent less than 5% of all asthmatic patients, children with severe asthma experience troublesome persistent symptoms, life-threatening attacks and side effects by oral corticosteroid treatment, that significantly impact on the quality of life and on economic costs. An accurate understanding of the mechanisms of the disease has been crucial for the discovery and development of biological therapies, for which children with severe asthma are candidates. The aim of this review is to discuss the use of approved biologics for severe asthma, providing updated evidence of novel targeted therapies in the pediatric age range.

引用

页码：195 / 204

页数：10

共 50 条

[11] Biologics and severe asthma in children
Saxena, Shikha
Rosas-Salazar, Christian
Fitzpatrick, Anne
Bacharier, Leonard B.
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 23 (02) : 111 - 118
[12] Clinical phenotypes of severe asthma with fungal sensitization and treatment with biologics
Guida, G.
Badiu, I
Antonelli, A.
Noceti, P.
ALLERGY, 2019, 74 : 428 - 428
[13] Combined Treatment of severe Asthma with multiple Biologics appears to be safe
不详
ALLERGOLOGIE, 2022, 45 (10) : 720 - 720
[14] Biologics for the treatment of severe asthma: Current status report 2023
Cetin, Gulden Pacaci
Ozdemir, Secil Kepil
Bostan, Ozge Can
Oztop, Nida
Sozener, Zeynep Celebi
Karakaya, Gul
Akkor, Asli Gelincik
Yilmaz, Insu
Mungan, Dilsad
Bavbek, Sevim
TUBERKULOZ VE TORAKS-TUBERCULOSIS AND THORAX, 2023, 71 (02): : 176 - 187
[15] Biologics in the Treatment of Asthma
Casan Clara, Pere
Martinez Gonzalez, Cristina
ARCHIVOS DE BRONCONEUMOLOGIA, 2020, 56 (03): : 137 - 138
[16] Biologics for the treatment of asthma
Laffman-Johnson, Elise
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 93 (03) : 220 - 221
[17] The emergence of new biologics for severe asthma
Eger, Katrien A. B.
Bel, Elisabeth H.
CURRENT OPINION IN PHARMACOLOGY, 2019, 46 : 108 - 115
[18] BIOLOGICS SWITCH IN SEVERE EOSINOPHILIC ASTHMA
Caminati, Marco
Guarnieri, Gabriella
Bagnasco, Diego
Bianchi, Fulvia Chieco
Carpagnano, Elisiana
Maule, Matteo
Molena, Beatrice
Pelaia, Girolamo
Pini, Laura
Senna, Gianenrico
Vianello, Andrea
Crisafulli, Ernesto
EUROPEAN RESPIRATORY JOURNAL, 2021, 58
[19] THE USE OF BIOLOGICS IN THE MANAGEMENT OF SEVERE ASTHMA
van Zyl-Smit, Richard N.
Masuku, David
CURRENT ALLERGY & CLINICAL IMMUNOLOGY, 2018, 31 (04) : 212 - 216
[20] Biologics and airway remodeling in severe asthma
Varricchi, Gilda
Ferri, Sebastian
Pepys, Jack
Poto, Remo
Spadaro, Giuseppe
Nappi, Emanuele
Paoletti, Giovanni
Virchow, Johann Christian
Heffler, Enrico
Canonica, Walter G.
ALLERGY, 2022, 77 (12) : 3538 - 3552

← 1 2 3 4 5 →